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Abstract
Dietary management in pediatric chronic kidney disease (CKD) is an area fraught with uncertainties and wide variations in
practice. Even in tertiary pediatric nephrology centers, expert dietetic input is often lacking. The Pediatric Renal Nutrition
Taskforce (PRNT), an international team of pediatric renal dietitians and pediatric nephrologists, was established to develop
clinical practice recommendations (CPRs) to address these challenges and to serve as a resource for nutritional care. We present
CPRs for energy and protein requirements for children with CKD stages 2–5 and those on dialysis (CKD2–5D). We address
energy requirements in the context of poor growth, obesity, and different levels of physical activity, together with the additional
protein needs to compensate for dialysate losses.We describe how to achieve the dietary prescription for energy and protein using
breastmilk, formulas, food, and dietary supplements, which can be incorporated into everyday practice. Statements with a low
grade of evidence, or based on opinion, must be considered and adapted for the individual patient by the treating physician and
dietitian according to their clinical judgment. Research recommendations have been suggested. The CPRs will be regularly
audited and updated by the PRNT.
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Introduction
Poor nutrition is one of the best described causes of poor
growth in children with chronic kidney disease (CKD) (1).
Malnutrition is also associated with worsening uremic symp-
toms and can lead to protein-energy wasting and increased
mortality. Conversely, obesity is a worldwide problem that is
also increasingly affecting the CKD population (2).
In 2009, the National Kidney Foundation Kidney Disease
Outcomes Quality Initiative (KDOQI) published comprehen-
sive nutritional guidelines (3). The Pediatric Renal Nutrition
Taskforce (PRNT) provides clinical practice recommenda-
tions (CPRs), updated wherever there is new evidence subse-
quent to the publication by KDOQI, on various aspects of the
dietary management of children with kidney diseases; this
document focuses on energy and protein requirements. The
composition of the PRNT, limitations, and grading of evi-
dence, and plans for audit and revision of the CPRs have been
previously described (4).
Nutritional assessment is necessary to determine an indi-
vidual’s dietary prescription; the methods and tools for this
assessment are described in the KDOQI guidelines (3).
Additional information about nutritional management in
CKD not covered here, including potassium, sodium, and
micronutrients, is discussed by KDOQI (3) and will be ad-
dressed by the PRNT in future CPRs. As with all documents
produced by the PRNT, the practical day-to-day management
of the nutritional prescription will be developed by the
Taskforce during the dissemination phase of the guideline (4).
Methods
Existing guidelines on energy and protein requirements for
age and gender in healthy children were reviewed and used
to help determine recommendations for children with CKD
stages 2–5 and when on dialysis (CKD2–5D).
Terminology
The recommendations for dietary requirements for energy
and nutrients, published by national and international
health bodies, are expressed in various terms and repre-
sent different measures. These are detailed in the
Supplementary Tables 1a and 1b.
We have not endorsed any one set of published values for
energy and protein requirements but have taken a pragmatic
approach and taken the range of requirements from the nation-
al health bodies for our recommendations. Since the national
and international terms for energy and protein requirements
have different definitions (and are therefore not directly com-
parable), and as we show a range of the published values, we
will use a novel term: Suggested Dietary Intake (SDI) for our
recommendations. The SDI comprises a range of values. The
lower and upper limits of the SDI for energy fall within the
average amount given in the published values (i.e., the daily
amount of energy considered sufficient to meet the needs of
half the population). The lower and upper limits of the SDI for
protein fall within the average amount + 2 SD given in the
published values (i.e., the daily amount of protein considered
sufficient to meet the needs for nearly all (97.5%) of the pop-
ulation) (Supplementary Fig. 1). The SDI may be used for
formulating dietary prescriptions and assessing the adequacy
of dietary intake in individuals.
Development process
The full development process for the CPRs and their purpose
has been published (4). PICO (Patient, Intervention,
Comparator, and Outcome) questions have been developed
in order to develop recommendations that provide specific
actionable advice, including choosing between alternative ap-
proaches in particular clinical situations.
PICO questions
Population: Children from birth to 18 years of age with
CKD2–5D.
Intervention: Nutritional requirements for energy and pro-
tein in children at different stages of CKD.
Comparator: Nutritional requirements for energy and pro-
tein in age-matched healthy children.
Outcomes: Energy and protein requirements to support nor-
mal growth and development in children with CKD2-5D.
Literature search
Details of the literature search are described in Supplementary
Table 2. After a critical review of the literature for each PICO
question, CPRs were derived and graded using the American
Academy of Pediatrics grading matrix (5) (Supplementary
Table 3). TheDelphimethod was used as previously described
(4) to seek consensus from experts in the field.
Clinical practice recommendations
1. What are the energy requirements
for children with CKD stages 2–5D?
1.1We suggest that the initial prescription for energy intake in
children with CKD2–5D should approximate that of healthy
children of the same chronological age. (Level B; moderate
recommendation).
1.2 To promote optimal growth in those with suboptimal
weight gain and linear growth, we suggest that energy intake
should be adjusted towards the higher end of the suggested
dietary intake (SDI). (Level D; weak recommendation).
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1.3 In overweight or obese children, adjust energy intake to
achieve appropriate weight gain, without compromising nutri-
tion. (Level X; strong recommendation).
Evidence and rationale
Healthy children The optimal energy requirement is the
energy from food needed to maintain normal body mass,
growth, and development, and to support a level of phys-
ical activity consistent with long-term good health.
Energy requirements are affected by physical activity,
growth, lean body mass, genetics, ethnicity, the environ-
ment, and current nutritional status.
Recommendations for energy intake come from observa-
tional and experimental studies and, more recently, studies
using doubly labeled water (DLW) along with a factorial
method to address physical activity (6–13). The DLW tech-
nique is considered the “gold standard” for assessing total
energy expenditure (TEE) in free-living individuals. TEE in-
cludes physical activity energy expenditure (the most variable
component of TEE), resting energy expenditure (REE), and
the thermic effect of food.
There are many guidelines for energy requirements
(Supplementary Table 4a) for the healthy population
(6–13). The definitions for the terms used are in
Supplementary Table 1a.
Children with CKD2–5D The 2009 KDOQI guidelines recom-
mend an energy intake for children with CKD stages 2–5D of
100% of the estimated energy requirement (EER) for chrono-
logical age and that further adjustment to energy intake should
be based upon the response in terms of the rate of weight gain
or loss (3). These statements were level B recommendations.
Subsequent studies provide no reason to change these guide-
lines, but we suggest using the SDI to serve as the standard for
energy requirements (Table 1).
There have been two strategies to investigate the optimal
requirements for energy for children with CKD since publica-
tion of the KDOQI guidelines. First, four trials studied REE/
basal metabolic rate (BMR) by indirect calorimetry and
showed no difference from healthy children after adjustment
for lean body mass (14–17). One trial measured BMR by
indirect open circuit calorimetry in 20 children with CKD
and 20 healthy age- and gender-matched controls (17). The
adjusted BMR of childrenwith CKD did not differ significant-
ly from healthy subjects. Second, observational and retrospec-
tive studies have reported the effects of specified energy intake
measurements in children with CKD (18–40). Most reported
that dietary energy intakes of around 100% of EER in children
with CKD, managed conservatively or on peritoneal dialysis,
resulted in acceptable growth (19–25, 30, 32, 33). The largest
prospective trial enrolled 65 children aged 2 to 16 years with
an estimated glomerular filtration rate (eGFR) < 75 ml/min/
1.73 m2 body surface area (BSA) (40). In the 51 completing
the study, growth was normal with median energy intakes of
94–98% of estimated average requirement (EAR) at baseline
and 85–94% of EAR at 2 years of follow-up.
In children on peritoneal dialysis (PD), energy intake from
dialysate must be considered, with reports of 7.5 ± 7 to 9.08 ±
4.13 kcal/kg/day (41, 42), depending on peritoneal glucose
exposure (glucose concentration of the dialysate, time on di-
alysis, cycles, and dwell times) and peritoneal membrane
transporter status. While some children may benefit from this
additional energy, if there is excessive weight gain, this energy
source needs to be taken into account when considering the
balance of macronutrients (protein, carbohydrate and fat) pro-
vided by the diet.
Indeed, obesity is increasing worldwide, even in children
with CKD: the International Pediatric PD Network (IPPN)
registry found a 19.7% prevalence of overweight/obesity in
children at the start of chronic PD (compared with 8.9% un-
derweight) (2). The Chronic Kidney Disease in Children
(CKiD) study has shown the median energy and protein con-
sumption to be higher than recommended in all age groups,
implying that at least half the children consumed more energy
and protein than recommended (43, 44). Modification of en-
ergy intake and lifestyle changes, including physical activity,
may be needed (3).
2. What are the protein requirements
for children with CKD stages 2–5D?
2.1 We suggest that the target protein intake in children with
CKD2–5D is at the upper end of the SDI to promote optimal
growth. (Level C; moderate recommendation). The protein
intake at the lowest end of the range is considered the mini-
mum safe amount and protein intake should not be reduced
below this level. (Level X; strong recommendation).
2.2 We suggest that the protein intake in children on dial-
ysis may need to be higher than the SDI for non-dialysis
patients to account for dialysate protein losses. (Level C; weak
recommendation).
2.3 In children with persistently high blood urea levels, we
suggest that protein intake may be adjusted towards the lower
end of the SDI, after excluding other causes of high blood urea
levels. (Level C; moderate recommendation).
Evidence and rationale
Healthy children The protein requirement is the amount of
protein needed for growth and to balance the losses of ni-
trogen from the body in individuals maintaining energy bal-
ance. We have considered all recent reports citing daily pro-
tein needs and we have focused on those using the linear
regression approach and the factorial method to inform their
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guidelines (7, 8, 10, 13, 45–48) (Supplementary Table 4b).
Age-appropriate ranges from these guidelines have been
adopted to create the SDI for protein. The data from
Agence Française de Sécurité Sanitaire des Aliments
(AFSSA) (48) have been excluded due to the wide range
of values given which lie outside of the ranges of the other
guidelines considered.
Protein is a fundamental component of cellular and
organ function. Together with sufficient protein provision,
there must also be adequate non-protein energy (i.e., car-
bohydrates, fats) available in order that the carbon skele-
tons of amino acids are not utilized to meet energy needs
(49). Furthermore, unless amino acids are present in the
correct balance in an individual’s diet, protein utilization
will be negatively affected (49). Dietary protein is needed
to maintain protein turnover and to synthesize physiolog-
ically important products of amino acid metabolism to lay
down as new tissue.
Nitrogen balance can be used to derive estimates of nitro-
gen protein requirements. The usual approach is based on the
regression of nitrogen balance (the equilibrium between intake
and loss) on intake. The average protein requirement is based
on nitrogen loss by urine, stool, hair, nails, and transpiration
(50) plus the extra protein needed for growth (51). The nitro-
gen amount is calculated and converted to protein with the
factor 6.25. The protein requirements for individuals follow-
ing lacto-ovo vegetarian and vegan diets, in order to achieve
the right amount and balance of high quality protein, are 1.2
and 1.3 times higher, respectively, than for people consuming
a mixed animal- and plant-based diet (8) due to the lower
bioavailability of non-animal protein.
Children with CKD2–5D The 2009 KDOQI guidelines (3) sug-
gested maintaining an intake of dietary protein at 100 to 140% of
the dietary reference intake (DRI) for ideal body weight in chil-
drenwithCKDstage 3 and at 100 to 120%of theDRI in children
Table 1 Energy and protein
requirements for infants, children
and adolescents with CKD2–5D
aged 0–18 years
SDI for energy and protein: birtha to 18 years
Month SDIb energy (kcal/kg/day) SDI protein (g/kg/day) SDI protein (g/day)
0 93–107 1.52–2.5 8–12
1 93–120 1.52–1.8 8–12
2 93–120 1.4–1.52 8–12
3 82–98 1.4–1.52 8–12
4 82–98 1.3–1.52 9–13
5 72–82 1.3–1.52 9–13
6–9 72–82 1.1–1.3 9–14
10–11 72–82 1.1–1.3 9–15
12 72–120 0.9–1.14 11–14
Year SDI energy (kcal/kg/day) SDI protein (g/kg/day) SDI protein (g/day)
– Male Female
2 81–95c 79–92c 0.9–1.05 11–15
3 80–82 76–77 0.9–1.05 13–15
4–6 67–93 64–90 0.85–0.95 16–22
7–8 60–77 56–75 0.9–0.95 19–28
9–10 55–69 49–63 0.9–0.95 26–40
11–12 48–63 43–57 0.9–0.95 34–42
13–14 44–63 39–50 0.8–0.9 34–50
15–17 40–55 36–46 0.8–0.9 Male: 52–65
Female: 45–49
For children with poor growth, reference to the SDI for height age may be appropriate. Height age is the age that
corresponds to an individual’s height when plotted on the 50th centile on a growth chart
a Thirty-seven/40 weeks gestation. Premature infants have higher energy and protein requirements. The increased
need for these and other particular nutrients (sodium, potassium, calcium, and phosphorus) must be balanced
against the nutritional interventions to control the effects of CKD. This is outside the scope of this CPR
b Suggested Dietary Intake (SDI) is based on the Physical Activity Level (PAL) used by the international bodies:
1–3 year PAL 1.4; 4–9 year PAL 1.6; and 10–17 year PAL 1.8. Where guidelines have given a range of energy
requirements for different levels of PAL, the lowest PAL has been taken for SDI energy in consideration that
children with CKD are likely to have low activity levels
c Scientific Advisory Committee on Nutrition (9) reports energy requirements as kcal/day: male 1040 kcal/day;
female 932 kcal/day
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with CKD stages 4 to 5 (level C). In children with CKD stage
5D, it was suggested that dietary protein intake be maintained at
100% of the DRI for ideal body weight plus an allowance for
dialytic protein and amino acid losses: for patients on PD 0.15–
0.3 g/kg/day and for patients on hemodialysis (HD) 0.1 g/kg/day
(level C) (3). Since the publication of the KDOQI guidelines,
there have been no studies that support adjustment of the above
statements, but we suggest using the SDI to serve as the standard
for protein requirements (Table 1).
Two randomized controlled trials (RCTs) have compared
low protein versus normal protein diets in children with CKD
(52, 53). At 8 months of age, 24 infants with an eGFR < 55 ml/
min/1.73 m2 were randomized to receive for 10 months either a
low protein formula of 1.4 ± 0.3 g/kg/day, with a protein-energy
(PE) ratio (the percentage of total dietary energy derived from
protein) of 5.6%; or control protein (2.4 ± 0.4 g/kg/day; PE ratio
of 10.4%). Significantly lower standard deviation scores (SDS)
for length and growth velocity were found in the low protein
diet group compared with controls (52). In the second trial, 226
CKD patients aged between 2 and 18 years were randomized to
the lowest safe protein intake (0.8 to 1.1 g/kg/day), as recom-
mended by theWorld Health Organization (WHO) (46), versus
an unrestricted protein intake; all patients were advised to have
a calorie intake of at least 70% of the WHO recommendations.
After 2 years of follow-up, neither the primary endpoint
(change in creatinine clearance) nor growth was different be-
tween the two groups (53). A Cochrane meta-analysis in 2007
concluded that there was uncertainty over the possibility of
harm associated with the provision of strict low protein diets
on growth in young infants (54).
Nitrogen balance studies are another option to estimate the
protein requirements of a specific population. In a study of 31
children on PD, a dietary protein intake of at least 1.45 g/kg/
day (= 144% of recommended daily allowance (RDA)) was
required to obtain an estimated nitrogen balance of +
50 mg/kg/day (55).
Based on the available evidence, restriction of dietary protein
in the early stages of CKD in children should be avoided. Most
importantly, a low protein intake may increase the risk of malnu-
trition, poor growth, and protein-energy wasting, which are com-
mon problems in this population. The ranges for protein SDI
given here are a starting point for the initial prescription of dietary
protein for feeding a child with CKD. Some children will be
consuming a higher protein intake, which can negatively affect
acid-base balance and urea levels; phosphate intake is also higher
in patients with a high protein intake (56–59). In 20 children on
PD, dietary protein intake was negatively correlated with plasma
bicarbonate, total body bone mineral density, bone mineral con-
tent, and fat-free mass (56). The impact of high phosphate intake
is discussed elsewhere (4).
PD is associated with significant protein losses in the dial-
ysate, and losses are higher in small children on chronic PD
compared to older children, ranging from 0.28 g/kg/day in
infants to 0.1 g/kg/day in adolescents (60); in turn, it is rea-
sonable to suggest that protein intake should be increased
accordingly. Peritoneal transport status characteristics and
the increase of peritoneal protein losses during peritonitis
should also be taken into account. There are no pediatric stud-
ies of amino acid and protein losses in extracorporeal dialysis,
while amino acid losses as high as 6–10 g/session have been
reported in adults treated with HD (61–63).
Children on intensified HD or hemodiafiltration often have
an unrestricted diet, as these dialysis modalities allow for bet-
ter volume and metabolic control (64).
Given the deleterious effects of acidosis and phosphate
load in children with CKD, a reduction of protein intake
could, in some cases, help improve metabolic control provid-
ed that nutritional status is preserved. Urea levels may be used
as an indicator of protein intake and may help determine when
a reduction in dietary protein intake might be considered. It is
not expected that children with CKD2–5D have urea levels in
the normal range. Indeed, low levels may indicate insufficient
dietary protein. In contrast, urea levels chronically higher than
expected for the degree of CKD are most commonly due to
excessive dietary protein relative to energy intake but may
also be secondary to a catabolic state, acute or chronic dehy-
dration, or steroid therapy. The urea level associated with ure-
mic symptoms is variable with age and between individuals.
Chronically high urea levels may be tolerated.
3. How is the nutritional prescription
for energy and protein provided for children
with CKD stages 2–5D?
3.1 Breastfeeding is the preferred method for feeding an infant
with CKD. (Level X; strong recommendation).
3.2 When breastfeeding is not possible or expressed
breastmilk is not available in adequate amounts for the infant
with CKD, we suggest that whey-dominant infant formulas be
used. (Level A; strong recommendation).
3.3 We suggest that breastmilk and infant formulas should
be fortified when there is a prescribed fluid restriction or when
a more energy or nutrient dense feed is required to meet nu-
tritional requirements. (Level A ; strong recommendation).
3.4 We suggest that the concentration of feeds and addition
of dietary supplements are prescribed in a gradual manner in
order to maximize acceptance and tolerance. (Level D; weak
recommendation).
Evidence and rationale
Breastmilk is the best source of nutrition for infants (65),
including those with CKD2–5D who may benefit from its
low renal solute load. Standard whey-dominant infant formu-
las have a protein and electrolyte content closer to that of
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breastmilk than casein-dominant formulas, so are the preferred
alternative and may be beneficial beyond the first year of life.
Do not use soya infant formulas under 12months of age due to
their high phytoestrogen content, unless there is a specific
medical indication.
The nutritional content of infant formulas may be concen-
trated in a smaller volume when there is a need for fluid re-
striction, or when normal feed volumes exacerbate vomiting
and gastro-esophageal reflux. Most standard infant formulas
are reconstituted to an approximate 13% concentration (i.e.,
13 g powder to 100 ml water, providing 67 kcal and 1.3 g
protein per 100 ml). It is suggested that this concentration may
be increased daily by 1–3%, up to 20% (i.e., 20 g powder to
100 ml water), depending on local practices and the infant’s
tolerance of feed changes. Infant formula powder may also be
added to expressed breastmilk (EBM) at a concentration of 3–
6% (i.e., 3–6 g infant formula powder to 100 ml EBM), in-
creasing the total energy density up to 1 kcal/ml. Breastmilk
fortifier may also be used for preterm infants.
Concentrating the formula should be done gradually to
ensure tolerance since the increase in osmolality (66) may
cause diarrhea, vomiting, and gastro-esophageal reflux. It also
increases the renal solute load and may lead to excessive in-
takes of phosphate, potassium, and other minerals and vita-
mins. Toxic levels of vitamin A are of particular concern (67).
In contrast, the majority of water-soluble vitamins are below
the dietary reference intake (DRI) (68, 69). In patients on
dialysis, certain vitamins (water-soluble vitamins B1, B5,
B6, folic acid, vitamin C) and zinc are lost excessively in the
dialysate; these may need to be supplemented over and above
the levels provided by the formula to meet recommended in-
takes. Recommendations regarding the vitamin intake for chil-
dren with CKD are included in the KDOQI guidelines (3).
An alternative is to use an infant formula at a normal con-
centration (or EBM if available) and to add protein powder
and/or energy modules (glucose polymers, fat emulsions, or
combined carbohydrate and fat preparations) to design a
patient-specific profile for energy and protein, with attention
to vitamin and mineral supplementation as necessary (24, 70,
71). This method of fortification is particularly used if con-
centrating the infant formula provides an intake of vitamin A,
potassium, or phosphate beyond desirable levels. A simple
recipe and caregiver education are required to reduce errors
in formula preparation (72). Energy and nutrient dense liquid
infant formulas are available commercially and may be useful.
The addition of glucose polymers, fat emulsions, and protein
powders to standard infant formula and EBM can be used for
oral feeding or tube feeding. If a mother wishes to continue
breastfeeding, this should be prioritized and incorporated into
the feeding plan as long as the infant’s overall nutritional
intake is not compromised.
To achieve optimal growth in the healthy infant with ap-
propriate deposition of lean and fat tissue, the PE ratio of the
infant formula should ideally be within the range 7–12%; a
high PE ratio is required for accelerated weight gain or catch-
up growth (Supplementary Table 5) (46). In CKD, the chal-
lenge is to preserve the PE ratio while adding non-protein
energy sources (carbohydrate and fat) to formula in order to
control abnormal blood biochemistry, such as elevated urea,
phosphate, or potassium levels. In these situations, it is impor-
tant to ensure that at least the SDI for protein is provided. A PE
ratio of 5.3–6.4% supported weight gain and linear growth in
children aged 0–2 years, provided at least 100% of protein
requirements were given (21), the lower PE ratio reflecting
an increase in energy provision rather than a low protein
intake.
Glucose polymers may be added in increments, e.g.,
1% daily (1 g extra added to 100 ml formula or EBM
per day, yielding an additional 4 kcal/100 ml). Gradual
increases will allow for identification of the concentration
at which the infant becomes intolerant (developing loose
stools, increased vomiting). Tolerance to increased carbo-
hydrate concentration depends on the age of the infant,
and the maturity and absorptive capacity of the gut, with
some infants more tolerant to a more rapid addition of a
glucose polymer.
Fat emulsions may be used and should also be added in-
crementally, e.g., 1% daily (1 ml added to 100 ml formula or
EBM per day) to provide an increase of 0.5 g fat per 100 ml
(an additional 5 kcal/100 ml). The increased fat content may
delay gastric emptying and cause nausea and vomiting. See
Table 2 for suggested percentage concentrations of carbohy-
drate and fat that may be tolerated.
Hyperkalemia occurs as CKD progresses and is more pro-
nounced in patients with metabolic acidosis. Usually reduced
potassium intake is indicated (3), but hyperkalemia can result
from cell catabolism when there is deficient energy intake.
This can be resolved by the addition of energy modules to
the infant’s usual formula or EBM.
Protein powders are added to formulas or EBM to provide
a specific amount of protein per kilogram of body weight.
Additional protein is particularly important for the child on
PD to compensate for protein losses in dialysate (60).
Protein intake should be increased by at least 0.15–0.3 g/kg/
day for children on PD, 0.1 g/kg/day for HD (3). Supplements
should be added in small increments, 0.1 g protein/kg/day, and
urea levels measured to detect excessive intake (i.e., urea
levels above expected for degree of CKD). On occasion, mea-
surement of dialysis protein losses may help guide a plan for
protein supplementation.
3.5 Solid foods should be introduced as recommended for
healthy infants, with progression to varied textures and con-
tent according to the infant’s cues and oral motor skills. We
suggest that all children eat a healthy, balanced diet with a
wide variety of food choices, as for the general population,
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taking into account possible dietary limitations. (Level D;
weak recommendation).
3.6 Oral feeding is the preferred route whenever possible.
Oral stimulation is desirable, even if oral intake is limited, to
prevent the development of food aversion. (Level C; weak
recommendation).
Evidence and rationale
Whilst exclusive breastfeeding for the first 6 months of life is
recommended by the WHO and supported by a systematic
review (65), the age when solid foods are introduced for in-
fants with CKD should be managed individually. Delayed
exposure to pureed and more textured foods may cause feed-
ing problems (73). The nutritional content of solid food must
be balanced against that provided by the formula in order to
achieve optimum intake of energy, protein, and other nutri-
ents. Dietary limitations in potassium and phosphate may be
necessary according to the stage of CKD and abnormal blood
biochemistry. A low potassium or phosphate formula may be
given so that dietary restrictions can be liberalized to allow a
greater variety of foods to be offered. A more liberal oral
intake may encourage more normal development and behav-
iors around food.
From 1 year of age, commercially available fortified milk
drinks (with a suitably low phosphate and potassium content)
may be useful as they contain iron, vitamin D, and n-3 polyun-
saturated fatty acids, which may enhance the diet of the toddler
with CKD.Also known as “YoungChild Formulas,” they are not
routinely recommended for healthy children (74).
Infants and young children with CKD2–5D may be reluc-
tant to take an oral diet. At the same time, tube feeding is
associated with long-lasting feeding difficulties, such as
chewing and swallowing problems, food refusal, panic attacks
(75), and poor development of oral motor skills (73). An im-
portant aspect of nutritional treatment is therefore to enable as
normal development of feeding and eating as possible. When
there are significant feeding difficulties, speech and language
therapy may help caregivers with the provision of oral feeding
and with non-nutritive oral stimulation; input from a psychol-
ogist, including family therapy, may be considered (73).
Whilst encouraging an oral diet, there is a need to educate
families about healthier food choices at the time of introduc-
tion of solids in order to influence later dietary habits. Besides
undernutrition, obesity is common in the CKD population and
the frequency is similar to that of the normal population. A
food frequency questionnaire (FFQ) in 658 children aged 2–
18 years with mild to moderate CKD in North America has
highlighted some undesirable eating habits (44). Fast foods
were a major contributor of sodium, phosphorus, energy,
and fat intake, with cow’s milk and milk products contributing
7.7% of energy, 13.8% of protein, 4.6% of sodium, 20.3% of
phosphate, and 15.9% of potassium intakes. Dietary and life-
style changes to achieve weight control are discussed by
KDOQI (3).
3.7 We suggest prompt intervention once deterioration in
weight centile is noted. Oral nutritional supplementation should
be started in children with inadequate dietary intake, after con-
sideration of medical management of correctable causes of re-
duced intake. (Level B, moderate recommendation).
Evidence and rationale
Growth is most rapid in the first year of life, and failure to gain
weight is the signal for intervention. If weight is static for just
2 weeks in the first 3 months of life, there is a loss of 1 centile;
if static for 4 weeks, 2 centiles are lost; at 6 months of age,
there is a loss of 1 centile after a 3 week period of no weight
gain; and at 9 months, 1 centile is lost after 4 weeks of static
weight. Weight and/or head circumference measurements are
more sensitive markers of poor growth in infants with CKD
when length/height measurements are often inaccurate.
Table 2 Suggested addition of energy modules to formulas
Energy module Age Amount of CHO/fat module added to formula Final concentration of
CHO/fat in formula
(% or g/100 mL)
Glucose polymer < 6 months 3–5 g (+ 7 g CHO from infant formulaa) 10–12
6 months–1 year 5–8 g (+ 7 g CHO from infant formulaa) 12–15
> 1 year 8–18 g (+ 12 g CHO from pediatric formulaa) 20–30
Fat emulsion (50% fat content) < 1 year 3–5 ml (+ 3.5 g fat from infant formulaa) 5–6
> 1 year 9 ml (+ 4.5 g fat from pediatric formulaa) 9
Adapted from Shaw V (ed) Clinical Paediatric Dietetics, 4th edition (2015). Chichester: Wiley Blackwell, page 18
CHO carbohydrate
a CHO and fat contents of formulas vary
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The first step in response to poor weight gain is to address
any correctable causes of reduced dietary intake, such as
gastro-esophageal reflux/vomiting (by means of feed thick-
eners, alginates, antacids, histamine H2 receptor antagonists,
proton pump inhibitors, sucralfate, prokinetics), acidosis, vol-
ume overload, or inadequate dialysis. Children with CKD
may also not achieve adequate oral intake due to reduced
appetite, altered smell and taste, and abnormal hormone reg-
ulation (76–88) (Supplementary Table 6). When inadequate
energy and protein intake persists, nutritional supplementation
should be instituted. Many studies in children with CKD sug-
gest that growth deteriorates without supplemental feeding
and that with dietary intervention by the oral route or with
enteral tube feeding, this deterioration can be diminished
(18, 21, 22, 29, 36, 38, 40, 43, 89–95). In children with salt-
wasting forms of CKD, salt supplementation is also necessary
for optimal growth (3).
Energy and protein modules can be added to EBM, stan-
dard infant formulas, and infant renal specific formulas.
Alternatively, standard pediatric enteral formulas can be
fortified if the child will drink them. Standard adult enteral
and renal specific formulas can be modified, if necessary, to
meet the nutritional requirements of infants and children, but
with particular attention to their vitamin and mineral content,
which may be excessive.
For those children who are eating, these modules can also
be added to normal foods and beverages to meet energy and
protein requirements. Where vitamin and mineral intake is
also lacking, the first line of treatment is to give nutritionally
complete oral liquids (also known as oral nutritional supple-
ments or sip feeds) suitable for toddlers, older children, and
adolescents. If there are concerns with elevated electrolyte
levels, a palatable high energy pediatric renal specific oral
nutritional supplement can be used, when available.
Glucose polymers can be added to beverages, starting with
5% (5 g added to 100 ml) and increasing to 20–30% as need-
ed, and also to “liquid” foods such as porridge/hot breakfast
cereals and custards/soft desserts. Sugar and glucose may also
be used, but the quantity may be limited due to their sweet
taste and osmotic effect on the gut. Extra fat in the form of
Table 3 Summary of recommendations
Category Recommendation Grade
1 Energy requirements 1.1 We suggest that the initial prescription for energy intake in children with CKD2–5D should
approximate that of healthy children of the same chronological age.
Level B; moderate recommendation
1.2 To promote optimal growth in those with suboptimal weight gain and linear growth, we
suggest that energy intake should be adjusted towards the higher end of the suggested
dietary intake (SDI).
Level D; weak recommendation
1.3 In overweight or obese children, adjust energy intake to achieve appropriate weight gain,
without compromising nutrition.
Level X; strong recommendation
2 Protein requirements 2.1 We suggest that the target protein intake in children with CKD2–5D is at the upper end of
the SDI to promote optimal growth.
The protein intake at the lowest end of the range is considered the minimum safe amount and
protein intake should not be reduced below this level.
2.2 We suggest that the protein intake in children on dialysis may need to be higher than the
SDI for non-dialysis patients to account for dialysate protein losses.
2.3 In children with persistently high blood urea levels, we suggest that protein intake may
be adjusted towards the lower end of the SDI, after excluding other causes of high blood
urea levels.
Level C; moderate recommendation
Level X; strong recommendation
Level C; weak recommendation
Level C; moderate recommendation
3 Nutritional prescription 3.1 Breastfeeding is the preferred method for feeding an infant with CKD.
3.2 When breastfeeding is not possible or expressed breastmilk is not available in adequate
amounts for the infant with CKD, we suggest that whey-dominant infant formulas be used.
3.3 We suggest that breastmilk and infant formulas should be fortified when there is a
prescribed fluid restriction or when a more energy or nutrient dense feed is required to meet
nutritional requirements
3.4 We suggest that the concentration of feeds and addition of dietary supplements are
prescribed in a gradual manner in order to maximize acceptance and tolerance.
3.5 Solid foods should be introduced as recommended for healthy infants, with progression to
varied textures and content according to the infant’s cues and oral motor skills. We suggest
that all children eat a healthy, balanced diet with a wide variety of food choices, as for the
general population, taking into account possible dietary limitations.
3.6 Oral feeding is the preferred route whenever possible. Oral stimulation is desirable, even if
oral intake is limited, to prevent the development of food aversion.
3.7 We suggest prompt intervention once deterioration in weight centile is noted. Oral
nutritional supplementation should be started in childrenwith inadequate dietary intake, after
consideration of medical management of correctable causes of reduced intake.
3.8 We suggest that supplemental or exclusive enteral tube feeding should be commenced in
children who are unable to meet their nutritional requirements orally, in order to improve
nutritional status.
Level X; strong recommendation
Level A; strong recommendation
Level A; strong recommendation
Level D; weak recommendation
Level D; weak recommendation
Level C, weak recommendation
Level B, moderate recommendation
Level B, moderate recommendation
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vegetable margarines or oils (preferably those with a high
content of omega-3 fats, such as olive, walnut, or rapeseed
oil), and jams, honey, or syrups can be added to foods. Other
options include alternative “milks” derived from plants, such
as soy, oat, almond, or coconut, without calcium phosphate
fortification. It is not advisable to give rice milk to infants and
young children due to its high arsenic content. Fruit juices, or
alternatively concentrated fruit flavorings (cordials) if there is
hyperkalemia, can be provided; protein-free milk replacement
drinks, which have low phosphate contents, can serve as a
supplement. Glucose absorbed from PD fluid (41, 42) contrib-
utes to total energy intake.
It is rarely necessary to add protein modules to foods for
children with CKD2–5, but they may be useful for those on
dialysis, choosing low phosphate preparations. Most liquid
oral renal specific supplements designed for adults are low
volume and can be provided between meals in small portions
without compromising appetite.
No recommendation can be made for using dietary supple-
ments of essential amino acids and ketoacids in children with
CKD. In a trial with 20 children and adolescents, a low protein
diet (0.6 g/kg/day) with ketoacid supplements led to a statistically
significant (p < 0.001) increase in height SD (from − 1.93 ± 1.76
to − 1.37 ± 1.58) when compared to a diet providing the RDA for
protein (96). A study of 20 infants with an eGFR < 30–75 ml/
min/1.73 m2 (not tube fed), and a diet containing 1.8–2.2 g pro-
tein/kg/day with supplemental essential amino acids accounting
for 20% of the protein intake showed a decrease in weight and
height SD frombirth to 12months:− 0.26 to− 1.53 and− 0.56 to
−1.63, respectively (97).
3.8 We suggest that supplemental or exclusive enteral tube
feeding should be commenced in children who are unable to
meet their nutritional requirements orally, in order to improve
nutritional status. (Level B, moderate recommendation).
Evidence and rationale
Several retrospective studies in children with CKD have
shown improvement in weight/BMI SD with tube feeding
(18, 21, 22, 91–95). All but two of these studies (91, 95) also
showed an improvement in height SD. Although most of the
available evidence is for children under the age of 2 years, one
study reported an increase in weight and height SD specifical-
ly for children aged 2–5 years with tube feeding (21). In these
studies, tube feeds provided as much as 100% of require-
ments, while others were supplemental to oral intake.
Three studies have not shown an association between tube
feeding and growth. In a questionnaire-based nested case-
control study on 137 dialysis patients, where 70% of the chil-
dren received tube feeds, there were no significant differences
in weight or height SDS up to 1 year after dialysis initiation in
patients receiving supplemental feedings compared to those
not receiving supplemental feedings (38). Two smaller pro-
spective studies also failed to detect an association between
energy intake and growth (29, 97).
Commercial formulas and expressed breastmilk are pre-
ferred for tube feeding and can be supplemented, if necessary,
as described above. Parents wishing to prepare their child’s
tube feeds by blending foods should be counseled by a qual-
ified dietitian about safety issues with this practice, including
nutritional quality, microbial contamination, and appropriate
equipment and administration (98).
When oral or tube feeding is not sufficient or possible,
usually as a result of intestinal failure, parenteral nutrition
may be needed and the prescription must be tailored for the
child with CKD. Intradialytic parenteral nutrition (IDPN) in
children is rarely indicated and does not confer a benefit over
enteral feeding (99). Studies are scarce (100–102) and no rec-
ommendations for its use can be given.
Ongoing oral stimulation is important in tube fed children
to help in the transition to normal feeding once they have had a
successful transplant (103, 104).
Results of the Delphi survey
The Delphi survey was sent to 41 pediatric nephrologists and
28 dietitians from 26 countries, with a 68% response rate (27
pediatric nephrologists and 20 dietitians). The names of all
respondents are listed under “Acknowledgments” below.
Of the 14 clinical practice recommendation statements,
overall, a 94.5% consensus was achieved with a “strongly
agree” or “agree” response, 4.1% had a “neutral” re-
sponse, 1.2% “disagree,” and 0.4% “strongly disagree”
response. On analysis of individual statements, 5 received
a disagree response, the highest rate being 5.4% to state-
ment 3.1. The respondents queried breastfeeding when
there are issues with weight gain and abnormal biochem-
istry, and commented that supplemental feeding is neces-
sary. These aspects are covered in the rationale supporting
statements 3.3 and 3.4. One statement received a strongly
disagree response, the highest rate being 5.4% to state-
ment 1.1. The respondents queried whether stage of
CKD, the presence of protein-energy wasting and
hypercatabolic state should be taken into consideration.
The studies supporting this statement included children
with CKD2–5D, and most reported that dietary energy
intakes of around 100% of that for healthy children result-
ed in acceptable growth.
The Taskforce team carefully reviewed all of the statements
in light of these responses; none required significant change.
However, there has been further clarification to the text and
tables as suggested by the respondents.
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Summary of recommendations
A summary of recommendations is provided in Table 3.
Research recommendations
We recommend the following areas of study to provide future
evidence based recommendations for energy and protein re-
quirements in children with CKD2–5D:
1. To investigate the outcomes (growth, morbidity, mortality,
quality of life) associated with the provision of optimum
energy and protein by tube feeding after the first 2 years of
life
2. To investigate the ideal protein-energy ratio for the opti-
mum deposition of lean mass versus fat mass and growth,
assessed with multi-component body composition models
3. To investigate why some children experience growth fail-
ure while others show excessive weight gain despite re-
ceiving the SDI for energy and protein
4. To investigate oral motor development of infants and
young children who are predominantly tube fed to en-
hance transition to oral feeding
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